Pharma Integrates 2022 Track 3
How do we enable a better Industry, through creating diverse skilled teams, empowering the patient and navigating the economic and regulatory environment?
Welcome and opening remarks
TIM FERRIS | National Director of Transformation | NHS England and NHS Improvement
JENNY OUSBEY | Chief Executive Officer & Founder | Ovid Health
LORD DAVID PRIOR | Deputy Chairman UK and Global Senior Advisor | Lazard
TAMSIN BERRY | Head of Policy and Partnerships, AreteiaTx | Partner, Population Health Partners
Patients in charge
How should we engage and empower patients in their healthcare journeys?
Jenny Ousbey | Chief Executive Officer & Founder | Ovid Health
Peter Bannister | Honorary Chair | University of Birmingham Centre for Regulatory Science and Innovation
Tim Ringrose | Chief Executive Officer | Cognitant
Nigel Brokenshire | Head of Digital Healthcare UK/I | Bayer PLC
Helen Quinn | Clinical Director | NIHR PRC: Exeter
Vive la difference
What is the evidence that we need to have more diverse and inclusive organisations?
How do we harness the diversity we know brings better business results?
What are the challenges in bringing diverse individuals together and how do we overcome them?
Kathryn Simpson | Business Consultant | Kathryn Simpson Consulting Limited
Michael George | Vice President, Global Head MedSci & iiGM Global Therapeutic Area Head | Labcorp Clinical Development Limited
Amina Udechuku | Head of Vaccines, UK | Takeda UK
Sally Moore | Director and Chartered Psychologist | Top Stream Coaching and Consulting
Melissa Hanna-Brown | Senior Director, Global External Strategic Innovation Lead | Pfizer
Are you in or out sourcing?
What is the strategic role of the CDMO and CRO? How has partnering changed?
James Fry | Partner and Head of Life Sciences, | Mills & Reeve
Catherine Blackman | Vice President for Therapy Supply Chain | GSK
Jason Cameron | Chief Operating Officer | Orphan Drug Consulting
Steve Barr | Vice President Business Development, | SK biotek
Steven Facer | Vice President of Business Development EU/ROW | Adare Pharma Solutions
James Crooks | EU Regulatory Affairs Director | ProductLife Group
Trials and tribulations
What are the latest innovations in clinical trials? How are this being adopted?
Stuart Redding | Chief Executive Officer | MRN
Michael Young | Co-founder | Lindus Health
Christopher Morton | Chief Executive Officer | ELEM Biotech
James Chennells | Head Clinical Trial Technology Strategy | Bayer
Helen Shaw | Co-Founder and Managing Director | The VCTC
Matthew McLoughlin | CEO and Founder | Synetic